Session 894: Angiogenesis

Date: 2 February 2004, Time: 11:30 - 13:30
Location: Room 4

Oral Presentations

Time	Number	Title / Authors / Affiliations
11:30	112	Anti-angiogenesis, biological therapies and chemoprevention A Albini PhD^a, N Ferrari PhD^a, M Morini PhD^a, R Benelli PhD^a, U Pfeffer PhD^a, DM Noonan PhD^a Laboratory of Molecular Biology and Neoplastic Progression Unit, National Cancer Research Institute, Genova, Italy. e-mail: adriana.albini@istge.it
11:50	113	Microarray gene expression profiling reveals interference of the anti-oxidants N-acetyl cysteine and (-)-epigallocatechin-3-gallate with the TNFa dependent inflammatory response of endothelial cells U Pfeffer PhD^a, N Ferrari^a, D Eva^a, M Morini^a, D Noonan^b, A Albini PhD^a ^aLaboratory of Molecular Oncology, ^bTumor Progression Unit; National Cancer Research Institute, Genova, Italy
12:05	114	Antiangiogenic tetrathiomolybdate protects against Her2/neu-induced breast carcinoma by hypoplastic remodeling of the mammary gland. Q Pan PhD, CG Kleer MD, LW Bao MD, SD Merajver MD PhD Department of Internal Medicine, Division of Hematology and Oncology, Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, United States
12:20	115	LMP-1 induces synthesis of hypoxia-inducible factor-1a JS Pagano MD^a, N Wakisaka MD PhD^b ^aUniversity of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, United States, ^bKanazawa University, Kanazawa, Japan
12:35	116	Novel design of inhibitory antibodies for human matrix metalloproteinases N Sela BSc^a, A Solomon MA^a, O Rosen MA^a, T Danon BA^a, PhD Sagi^a Department of Structural Biology, the Weizmann Institute of Science, Rehovot, ISREAL
12:50	117	Proposed explanation of mammography paradox for women age 40-49 M Retsky PhD^a, R Demicheli MD PhD^b, W Hrushesky MD^c (a) Children's Hospital/Harvard Medical School, Boston MA; (b) National Cancer Institute, Milan, Italy; (c) Dorn VA Center, Colombia SC.

Poster Presentations

Number	Title / Authors / Affiliations
118	Blockade of endothelin A receptor inhibits endothelin-1-induced cyclooxygenase-1 and -2 expression In ovarian cancer cells. F Spinella PhD, L Rosanò PhD, S Decandia, PhD Di Castro, MR Nicotra^a, PG Natali MD^b, A Bagnato PhD ^aLaboratories of Molecular Pathology and Ultrasctructure, Immunology, Regina Elena Cancer Institute, Rome, Italy, ^bInstitute of Molecular Biology and Pathology CNR, Rome, Italy
119	Blood flow in cutaneous melanoma determines long term recurrence and survival A Srivastava MS FRCS PhD^a, RE Mansel FRCS^b, JP Woodcock PhD^c, DS LE Hughes FRCS^b (a) Department of Surgical Disciplines, All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110029, India (b) Department of Surgery,(c) Department of Bioengineering, University of Wales College of Medicine Cardiff,UK, CF14 4XN
120	Use of power Doppler sonography and circulating angiogenic factors to assess the anti-angiogenic effect of Thalidomide in hepatocellular carcinoma C-N Chen MD PhD^a, C Hsu MD^b,c,e, L-T Chen MD PhD^g, C-Y Wu BS^b, F-J Hsieh MD^d, A-L Cheng MD PhD^b,c,f,g (a)Departments of Surgery, (b)Oncology, (c)Internal Medicine, (d)Obstetrics and Gynecology, National Taiwan University Hospital; (e)Graduate Institute of Clinical Medicine and (f)Institute of Toxicology, National Taiwan University College of Medicine; (g)Division of Cancer Research, National Health Research Institutes
121	Oral cancer gene therapy with angiostatin G Matsumoto PhD, Y Ohmi PhD, U Lee PhD, E Kubota PhD Department of Oral and Maxillofacial Surgery, Kanagawa Dental College, Yokosuka, Kanagawa, Japan